Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

Published:2019-08-06 Issue:9 Volume:71 Page:1450-1459
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Charles‐Schoeman Christina¹,DeMasi Ryan²,Valdez Hernan³,Soma Koshika⁴,Hwang Lie‐Ju³,Boy Mary G.⁴,Biswas Pinaki³,McInnes Iain B.⁵

Affiliation:

1. University of California Los Angeles

2. Pfizer Inc Collegeville Pennsylvania

3. Pfizer Inc New York New York

4. Pfizer Inc Groton Connecticut

5. University of Glasgow Glasgow UK

Funder

Pfizer

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40911

Reference55 articles.

1. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

2. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies

3. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies

4. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis

5. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis;Dessein PH;J Rheumatol,2005

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cardiovascular risk of JAK inhibitors in treating rheumatic diseases;International Journal of Rheumatic Diseases;2024-08

2. Low-Dose Glucocorticoids in Older Patients with Rheumatoid Arthritis: What Does the Evidence Say?;Drugs & Aging;2024-07-27

3. Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance;Rheumatology and Therapy;2024-07-26

4. Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge;Biomedicines;2024-07-19

5. Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis;Modern Rheumatology;2024-03-06